Case Study

Lymphoma Mouse Model—A20, Testing For New Immunotherapies In Oncology

Source: August Bioservices
iStock-1183376856-mice-mouse-study

Investigating new treatments for cancer is a core competency and a continuous research focus for August Bioservices. One of the most encouraging areas of research for emerging new therapeutics is immunotherapy. A few immunotherapies have demonstrated promising activity in pre-clinical settings and testing new therapies either alone or in combination a reliable and reproducible tumor model is warranted. At our dedicated in vivo testing facility in Celina, TN, August Bioservices has the in-house ability to perform the A20 (B cell lymphoma) syngeneic tumor model to support immune-oncology research.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: